|
|
||||||||
Ann Thorac Surg 2004;77:1021-1022
© 2004 The Society of Thoracic Surgeons
Division of Cardiothoracic Surgery,The University of Texas Medical Branch,301 University Boulevard,Galveston, TX 77551-0528, USA
e-mail: jzwische@utmb.edu
e-mail: rvertree@utmb.edu
| The first 20% of the full text of this article appears below. |
The use of heat to treat disease has existed as long as recorded history. Observations relevant to cancer show heat does the following: (1) selectively kills cells as a function of thermal dose (duration of exposure x degree of temperature elevation); (2) selectively kills S-phase and radiation-resistant cells; (3) partially inhibits DNA repair; (4) kills cells with a defective heat-shock response; and (5) is a stimulus for apoptosis. Tumor cells, therefore, are more vulnerable to heat than normal cells. The clinical application of hyperthermia, often in conjunction with chemotherapeutic agents, includes
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |